Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
833.00    4.00 (0.48%)
Bid:
833.00
Ask:
835.00
Spread: 2.00 (0.24%)
Market Cap: £786.55m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Director/PDMR Shareholding - Replacement

19 Aug 2025 11:08

RNS Number : 9183V
Polar Capital Holdings PLC
19 August 2025
 

19 August 2025

 

The following amendments have been made to the Director/PDMR Shareholding announcement released on 15 August 2025 at 9:42am under RNS No 5227V.

 

The prices have been amended.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Polar Capital Holdings plc ("Polar Capital" or the "Company")

 

Notification of Transactions by Persons Discharging Managerial Responsibilities (PDMRs)/Persons Closely Associated (PCAs)

 

The Company was notified on 13 August 2025 that Ms. Rachel Stynes purchased 1,801 ordinary shares of 2.5p each ("Ordinary Shares") following an automatic dividend reinvestment for her personal holding at an aggregated price of 486.55p per share. Following this transaction Ms. Stynes is interested in a total of 32,033 Ordinary Shares representing 0.03% of the Company's issued share capital.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Rachel Stynes

2

 

Reason for the notification

 

a)

 

Position/status

 

Head of Human Resources

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Polar Capital Holdings plc

b)

 

LEI

 

549300OXX7YE1947B825

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5p each

Identification code

GB00B1GCLT25

b)

 

Nature of the transaction

 

Acquisition following dividend reinvestment

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

487.59 pence per share

980

485.50 pence per share

821

d)

 

Aggregated information

as in 4 c) above

- Aggregated volume

1801

- Price

486.55 pence per share

 

e)

 

Date of the transaction

 

13/08/2025

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

Polar Capital +44 (0)20 7227 2700

Gavin Rochussen (Chief Executive)

Samir Ayub (CFO)

 

Deutsche Numis - Nomad and Joint Broker +44 (0)20 7260 1000

Giles Rolls (QE)

Charles Farquhar

 

Peel Hunt LLP - Joint Broker +44 (0)20 3597 8680

Andrew Buchanan

Sam Milford

 

Camarco +44 (0)20 7757 4995

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEPNFELSEFA
Date   Source Headline
12th Jul 202112:38 pmRNSDirector/PDMR Shareholding
8th Jul 20212:07 pmRNSAnnual Financial Report
8th Jul 20217:00 amRNSAuM Update
1st Jul 202111:07 amRNSDividend Declaration
1st Jul 202110:26 amRNSDirector Declaration
1st Jul 20217:00 amRNSGroup Audited Results for year ended 31 March 2021
29th Jun 20213:53 pmRNSForm 8.3 - Ultra Electronics Holdings PLC
7th Jun 20217:00 amRNSNotice of Results
1st Jun 20217:00 amRNSTotal Voting Rights
26th May 20215:35 pmRNSDirector/PDMR Shareholding
21st May 20212:21 pmRNSDirector/PDMR Shareholding
20th May 202111:36 amRNSIssue of Equity
20th May 202110:38 amRNSHolding(s) in Company
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 202112:45 pmRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSIssue of Equity
16th Apr 20217:00 amRNSDirector/PDMR Shareholding
15th Apr 20217:00 amRNSAuM Update
13th Apr 20214:27 pmRNSHolding(s) in Company
1st Apr 202110:44 amRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
25th Mar 20215:45 pmRNSHolding(s) in Company
18th Mar 20214:08 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSCompletion of Dalton SP LLP Acquisition
26th Feb 20214:33 pmRNSDirector/PDMR Shareholding
26th Feb 20214:32 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSIssue of Equity
1st Feb 20215:35 pmRNSIssue of Equity
1st Feb 20217:00 amRNSBlock listing Interim Review
1st Feb 20217:00 amRNSTotal Voting Rights
25th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSIssue of Equity
20th Jan 20215:25 pmRNSDirector/PDMR Shareholding
20th Jan 20215:22 pmRNSIssue of Equity
19th Jan 20219:39 amRNSIssue of Equity
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSIssue of Equity
14th Jan 20217:00 amRNSAuM Update
17th Dec 20207:00 amRNSAcquisition of Dalton Strategic Partnership LLP
4th Dec 202010:08 amRNSIssue of Equity
1st Dec 20207:00 amRNSTotal Voting Rights
25th Nov 20203:36 pmRNSIssue of Equity
19th Nov 20207:00 amRNSUnaudited interim results
16th Nov 20202:13 pmRNSForm 8.3 - CPL RESOURCES PLC
2nd Nov 20208:51 amRNSTotal Voting Rights
23rd Oct 20204:26 pmRNSNotice of Results
19th Oct 20207:00 amRNSTeam Acquisition Completion

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.